1. Home
  2. CRT vs PMVP Comparison

CRT vs PMVP Comparison

Compare CRT & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRT
  • PMVP
  • Stock Information
  • Founded
  • CRT 1991
  • PMVP 2013
  • Country
  • CRT United States
  • PMVP United States
  • Employees
  • CRT N/A
  • PMVP N/A
  • Industry
  • CRT Oil & Gas Production
  • PMVP Medicinal Chemicals and Botanical Products
  • Sector
  • CRT Energy
  • PMVP Health Care
  • Exchange
  • CRT Nasdaq
  • PMVP Nasdaq
  • Market Cap
  • CRT 65.1M
  • PMVP 55.1M
  • IPO Year
  • CRT 1992
  • PMVP 2020
  • Fundamental
  • Price
  • CRT $9.70
  • PMVP $1.15
  • Analyst Decision
  • CRT
  • PMVP Strong Buy
  • Analyst Count
  • CRT 0
  • PMVP 1
  • Target Price
  • CRT N/A
  • PMVP $5.00
  • AVG Volume (30 Days)
  • CRT 22.2K
  • PMVP 278.5K
  • Earning Date
  • CRT 01-01-0001
  • PMVP 08-07-2025
  • Dividend Yield
  • CRT 9.19%
  • PMVP N/A
  • EPS Growth
  • CRT N/A
  • PMVP N/A
  • EPS
  • CRT 0.99
  • PMVP N/A
  • Revenue
  • CRT $6,834,116.00
  • PMVP N/A
  • Revenue This Year
  • CRT N/A
  • PMVP N/A
  • Revenue Next Year
  • CRT N/A
  • PMVP N/A
  • P/E Ratio
  • CRT $9.75
  • PMVP N/A
  • Revenue Growth
  • CRT N/A
  • PMVP N/A
  • 52 Week Low
  • CRT $8.88
  • PMVP $0.81
  • 52 Week High
  • CRT $13.31
  • PMVP $1.82
  • Technical
  • Relative Strength Index (RSI)
  • CRT 41.50
  • PMVP 57.96
  • Support Level
  • CRT $9.74
  • PMVP $0.96
  • Resistance Level
  • CRT $9.99
  • PMVP $1.14
  • Average True Range (ATR)
  • CRT 0.18
  • PMVP 0.07
  • MACD
  • CRT 0.00
  • PMVP -0.00
  • Stochastic Oscillator
  • CRT 8.11
  • PMVP 65.28

About CRT Cross Timbers Royalty Trust

Cross Timbers Royalty Trust is a United States-based trust. The net profits interests are derived from producing royalty, overriding royalty interests, and working interest properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.

Share on Social Networks: